NDC 47426-504-03 - ZYNRELEF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 47426-504
- Requested NDC
- 47426-504-03
- Package NDCs from labels
- 47426-504-03, 47426-504-01
- Manufacturer
- Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions
- Effective date
- 2026-04-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ZYNRELEF | Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions | 2026-04-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47426-504-01 | ZYNRELEF | 1 in 1 KIT | SOLUTION | 1 | 16 | |
| 47426-504-03 | ZYNRELEF | 2.3 mL in 1 VIAL, SINGLE-DOSE | SOLUTION | 2.3 | 16 | |
| 47426-504-03 | ZYNRELEF | 1 in 1 CARTON | SOLUTION | 1 | 16 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | e1603665-bbce-48b3-9424-3646570ae9b8 | 2022-08-17 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Proficient Rx LP | b5d72a30-3d32-45ad-be81-3fe601d8912b | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 432c3937-a4fe-4c92-8452-9ed2dd2cfc9a | 2022-03-03 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 9392df66-a152-40e6-b43b-44dc46a23496 | 2021-08-10 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 10c3949c-0066-4b8a-8d35-937e1ce09bf8 | 2021-08-06 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 8f43b954-d1cb-4210-b479-5292c446cc74 | 2021-05-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| RIMSO-50 | DIMETHYL SULFOXIDE | Mylan Institutional LLC | 58b25d79-78f2-4953-b0c6-61658dc4ef0d | 2021-03-17 | Warnings, Adverse reactions | YOW8V9698H |
| meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 966ae650-ad7d-4de1-ab06-54992408fcfd | 2021-03-11 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 2a29daa9-74e5-4ed6-b5f1-ce04dc411b26 | 2020-07-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Exelan Pharmaceuticals Inc. | dfaac71c-dcc5-4b57-bf3b-616fccab96de | 2018-09-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.